Learn About Cold Urticaria

What is the definition of Cold Urticaria?
Cold urticaria is an allergic condition that affects the skin. Symptoms usually start in early adulthood. The most common symptom is a red, itchy rash that appears on the skin when it is exposed to the cold (e.g. cold weather or cold water). This reaction usually occurs within 5-10 minutes after exposure and can last for 1-2 hours. The exact cause of Cold urticaria is unknown. In some cases, it may be associated with an infection, insect bite, or blood cancer. It is diagnosed based on the symptoms and confirmed through tests that look for a specific reaction to cold.
What are the alternative names for Cold Urticaria?
  • Cold urticaria
  • Cold contact urticaria
  • Primary idiopathic cold urticaria
  • Urticaria idiopathic cold
Who are the top Cold Urticaria Local Doctors?
Elite in Cold Urticaria
Elite in Cold Urticaria
Berlin, BE, DE 

Dorothea Molawi-Terhorst practices in Berlin, Germany. Ms. Molawi-Terhorst is rated as an Elite expert by MediFind in the treatment of Cold Urticaria. Her top areas of expertise are Cold Urticaria, Hives, Chronic Spontaneous Urticaria (CSU), and Angioedema.

Elite in Cold Urticaria
Elite in Cold Urticaria
Golnik, SI 

Mojca Bizjak practices in Golnik, Slovenia. Bizjak is rated as an Elite expert by MediFind in the treatment of Cold Urticaria. Their top areas of expertise are Cold Urticaria, Hives, Chronic Spontaneous Urticaria (CSU), and Anaphylaxis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Cold Urticaria
Elite in Cold Urticaria
Hoppe Seyler Str. 9, 
Tuebingen, BW, DE 

Jasmin Deschner-Kuemmerle practices in Tuebingen, Germany. Ms. Deschner-Kuemmerle is rated as an Elite expert by MediFind in the treatment of Cold Urticaria. Her top areas of expertise are Familial Cold Autoinflammatory Syndrome, Neonatal Onset Multisystem Inflammatory Disease, Muckle-Wells Syndrome, and Mevalonate Kinase Deficiency.

What are the latest Cold Urticaria Clinical Trials?
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel-Group Study of Barzolvolimab in Participants With Cold Induced Urticaria and Symptomatic Dermographism (EMBARQ-COLDU and SD)

Summary: The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to placebo in participants with cold induced urticaria or symptomatic dermographism who remain symptomatic despite the use of H1-antihistamines.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center